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Background: Allograft valves are excellent substitutes for diseased or absent 
valves but undergo primary tissue degeneration. Fibroblast viability may 
determine resistance to valve deterioration. This study evaluated gene 
expression for procollagen by valve grafts and studied the effects of 
cryopreservation and histocompatibility on this property. Methods and 
results: Fresh and cryopreserved rat aortic valves were implanted hetero- 
topically into syngeneic or allogeneic recipients. Nonviable, cryothermally 
injured valves were used as negative controls. The grafts and native aortic 
roots were excised 3 days after implantation. Northern hybridization with 
a human procollagen ~1(I) complementary DNA probe was used to assess 
the expression of type I procollagen mRNA. The content of procollagen 
mRNA relative to 18S ribosomal RNA was evaluated by means of scanning 
densitometry. In situ hybridization was used to locate the areas of 
procollagen mRNA expression in the grafts. Both fresh and cryopreserved 
grafts exhibited greater expression than the native valve. This increase in 
expression was observed in both syngeneic and allogeneic grafts, but not in 
the negative control group. In situ hybridization showed a strong signal for 
procollagen in the aortic wall and a weak signal in the leaflet and 
myocardium in the viable grafts and in native tissues. Conclusions: Regard- 
less of preservation or allogenicity, fibroblast viability in aortic valve grafts 
persists after implantation. Increased gene expression for procollagen 
suggests a capacity for repair and regeneration. (J Thorac Cardiovasc Surg 
1997;114:421-7) 
A lthough aortic valve replacement with human allograft valves achieves excellent early results, 
eventual failure of these tissues is common. 1-4 The 
precise cellular events initiating allograft valve fail- 
ure are unclear. Heretofore, studies of the causes of 
allograft valve failure have not succeeded in conclu- 
sively determining the mechanisms of degeneration. 
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Ongoing controversies concern models of failure, 
demonstration of cellular viability, durability of the 
extracellular matrix, and the contribution of the 
immune response. 5' 6 Regardless of the specific cel- 
lular events associated with valve failure, significant 
morbidity and mortality and a need for reoperations 
are the results. Many investigators have speculated 
that the cell viability in aortic valve allografts is 
crucial in determining the long-term fate of the 
valve. 1'7-9 If this is true, then the specific cell 
population of greatest importance is likely to be the 
fibroblasts. These cells are by far the most abundant 
in aortic valves and are responsible for protein 
synthesis and structural integrity. 
Although previous examinations of aortic valve 
grafts have successfully demonstrated the presence 
or absence of endothelial cell viability in vivo, t° 
viability of the fibroblast population has not been 
demonstrated xcept in in vitro models. Unlike the 
endothelial cell, whose relatively rapid rate of rep- 
lication allows convenient methods of assessing via- 
bility, the fibroblast replicates lowly and less pre- 
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dictably. Consequently, the evaluation of in vivo 
fibroblast viability requires a method of study that is 
based on normal metabolic activities of the cell. 
Such a technique may be useful not only in demon- 
strating that the fibroblasts are alive, but also in 
showing that they are functioning in a way that may 
contribute to the structural integrity of the tissue. 
This investigation was undertaken to assess procol- 
lagen gene expression as a marker for fibroblast 
viability in aortic valve grafts in a rat model and to 
use this technique to evaluate the effects of cryo- 
preservation and histocompatibility on viability. 
Materials and methods 
Aortic valve implantation. Inbred male rats underwent 
heterotopic transplantation of aortic valve allografts as 
described by Yankah and associates. ~1 Under general 
anesthesia with intraperitoneal sodium pentobarbital (60 
mg/kg body weight), donor rats weighing 100 to 150 gm 
underwent a midline sternotomy, exposing the heart and 
ascending aorta. The aortic root was excised with a 1 mm 
cuff of ventricular muscle and a 5 mm portion of distal 
artery to permit construction of anastomoses. Some valves 
were transplanted immediately. All valves not used imme- 
diately were subjected to antibiotic sterilization and con- 
trolled-rate cryopreservation by CryoLife, Inc. (Marietta, 
Ga.). At the time of implantation, recipient rats weighing 
200 to 250 gm underwent sterile laparotomy and dissec- 
tion of the abdominal aorta. The recipient aorta was 
occluded proximally and distally with vascular clamps and 
divided. An end-to-end anastomosis of the distal end of 
the valve graft to the distal end of the native aorta was 
performed with 8-0 polypropylene suture. Then a similar 
end-to-end anastomosis between the proximal end of the 
graft and the proximal end of the native aorta was 
constructed. No leaflet was intentionally included in the 
suture line; thus it is possible that competence of the valve 
was maintained. Whether valve opening and closing actu- 
ally occurs in this model is unknown, however. The 
coronary ostia were sutured closed. The aortic clamps 
were removed, the abdomen was closed, and the animals 
were allowed to recover. All implantation procedures 
were performed with a stereoscopic zoom microscope 
with a usual magnification of 9×. The grafts were left in 
place for 3 days. Then the rats were again subjected to 
general anesthesia, the grafts and the native aortic roots 
were excised, and the animals were killed. 
All grafts used in this study were obtained from Lewis 
rats and were implanted into Lewis rats (syngeneic) or 
Brown-Norway rats (strongly allogeneic). Thus four ex- 
perimental groups of potentially viable grafts were stud- 
ied: fresh syngeneic, fresh allogeneic, cryopreserved syn- 
geneic, and cryopreserved allogeneic. To provide control 
valves composed of nonviable tissue, we implanted addi- 
tional valves after subjecting them to cryothermal injury. 
Each such valve was immersed in liquid nitrogen for 20 
seconds without cryoprotectant and completely thawed at 
room temperature. The freezing-thawing cycle was per- 
formed three times for each valve. All animals received 
humane care in compliance with the "Guide for the Care 
and Use of Laboratory Animals" prepared by the Institute 
of Laboratory Animal Resources and published by the 
National Institutes of Health (NIH Publication No. 86-23, 
revised 1985). 
Northern blot, in situ hybridization, and histology. The 
retrieved tissues were snap frozen, pulverized, and ho- 
mogenized. Total RNA was isolated by means of the 
guanidinium isothiocyanate extraction method. 12 Quanti- 
ties of RNA were determined by spectrophotometric 
absorbance at 260 nm. For Northern blot analysis, 5/xg of 
RNA was denatured and electrophoresed in a 1% form- 
aldehyde agarose gel, transferred to a nitrocellulose trans- 
fer membrane (Micron Separations Inc., Westboro, 
Mass.), and cross-linked to the membrane with short-wave 
ultraviolet light. The prehybridizing and hybridizing solu- 
tions contained 50% formamide, 1× Denhardt's solution, 
6× saline-sodium phosphate-ethylenediaminetetraacetic 
acid buffer (SSPE buffer), and 1% sodium dodecyl sulfate 
(SDS). Complementary DNA (eDNA) probes were la- 
beled with [32pldeoxycytidine triphosphate by random 
primer extension (PRIME-IT II, Stratagene, La Jolla, 
Calif.) and added to the hybridizing solution to a specific 
activity of I × 106 cpm/ml. Hybridization was performed 
at 42 ° C for 14 to 18 hours. The blots were then washed 
several times with a final wash in 0.1× standard sodium 
citrate (SSC) solution and 0.1% SDS at 37 ° C. The blots 
were exposed on Kodak X-omat film (Eastman Kodak 
Co., Rochester, N.Y.) at -70 ° C. The relative content of 
procollagen mRNA was evaluated by scanning densitom- 
etry with a PhosphorImager model 400S and ImageQuant 
quantitation software (Molecular Dynamics, Sunnyvale, 
Calif.). The closest upstream position of each band, 
respectively, was taken as the background of the image 
and subtracted from the total reading. RNA loading was 
normalized by comparison to 18S ribosomal RNA. Re- 
sults were expressed as the fold increase above value 
obtained from corresponding native aortic root controls. 
For in situ hybridization detection of procollagen 
mRNA and routine histologic preparation, tissues were 
frozen in cutting medium and cut into 8 /xm sections. 
After fixation, the samples were hybridized with a 35S- 
labeled human al(I ) procollagen oligo probe, and the 
background was stained by hematoxylin. Other sections 
were stained with hematoxylin-eosin forroutine histologic 
examination. 
Molecular probes. Procollagen as(I ) (HF677), a hu- 
man cDNA, and a 1.5 kb human cDNA for 18S ribosomal 
RNA were obtained from the American Type Culture 
Collection, Rockville, Maryland. The human oq(I) procol- 
lagen gene is 18 kb in length, and its coding information is
subdivided in 51 exons. 13 The human cDNA probe used in 
this study is cloned from human fibroblasts. It spans from 
the nucleotides coding for amino acid residue 787 in the 
triple helical domain for 270 base pairs into the 3' 
untranslated region. The sequences of the cq(I) procolla- 
gen oligo probe, TGATTGGTGGGATGTCTFCGTCTF, 
is 24 base pairs long, from exon 1 and exon 2 of the human 
al(I ) procollagen gene. Human probes can be used for 
study of rat tissues, because sequence conservation is
greater than 90% among all mammalian species. TM
Statistical analysis. All values are reported as group 
means _+ standard error of the mean. Statview 4.01 
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Fig. 1. Sections of aortic valve grafts and corresponding native aortic valves stained with hematoxylin and 
eosin. A valve leaflet from a cryopreserved allograft (A) and a native valve leaflet from the same animal (B). 
An aortic wall of a cryopreserved allograft (C) and a native aortic wall from the same animal (D). A valve 
leaflet from a cryopreserved syngeneic graft (E) and a native valve leaflet from the same animal (F). A valve 
leaflet of a cryothermally injured negative control graft (G) and a native valve leaflet from the same animal 
(H). (All original magnifications ×400.) 
(Abacus Concepts, Inc., Berkeley, Calif., 1993) was used 
for statistical analysis. Differences among groups were 
analyzed by means of analysis of variance. Post hoc 
comparisons between groups were then carried out with 
the use of Scheffe's F test. Differences were considered 
significant at the level p < 0.05. 
Fig. 1, A to H shows photomicrographs of hematoxylin- 
eosin-stained sections from aortic valve grafts and the 
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Fig. 2. Northern blot analysis of al(I ) procollagen gene 
expression i an aortic valve graft (G) and native aortic 
valve (N) 3 days after implantation. Panel A, Fresh 
syngeneic group. Panel B, Fresh allogeneic group. 
corresponding ative aortic tissues from the same animal. 
The cellularity of the cryopreserved allograft valve leaflet 
(Fig. 1, A) was similar to that of the native aortic valve 
leaflet (Fig. 1, B). The aortic wall of the cryopreserved 
allograft valve (Fig. 1, C) showed a similar cell density to 
that of the native aorta (Fig. 1, D). Also, the cryopre- 
served syngeneic valve leaflet (Fig. 1, E) and its corre- 
sponding native alve leaflet (Fig. 1, F) were of like 
cellular density. On the other hand, the cryothermally 
injured valve leaflet (Fig. 1, G) demonstrated a complete 
absence of cells, contrasting sharply with the native valve 
leaflet (Fig. 1,/4). 
As shown in Fig. 2, valve grafts exhibited gene expres- 
sion of type I procollagen as exemplified by the bands 
located at 4.7 and 5.7 kb. As compared with the corre- 
sponding native valve, the graft appeared to have more 
abundant procollagen gene expression. Table I demon- 
strates the densitometry-derived quantitative expression 
for procollagen mRNA in average arbitrary units corre- 
sponding to the volume obtained by scanning densitome- 
try. Compared with the native aortic valve, the transcrip- 
tional activity of al(I ) procollagen mRNA in each group 
of valve grafts except for the cryothermally injured group 
was approximately threefold greater. Cryopreserved grafts 
and fresh grafts exhibited similar degrees of up-regulation 
of procollagen gene expression, as did syngeneic and 
allogeneic grafts. Only in the cryothermally injured con- 
trols was procollagen gene expression less than that in the 
native aortic roots. 
In situ hybridization confirmed the Northern blot find- 
ings (Figs. 3 to 5). Both in native aortic roots and in the 
grafted valves, there was gene expression for type I 
Fig. 3. Dark-field photomicrograph showing localization 
of al(I ) procollagen mRNA by in situ hybridization i a 
fresh syngeneic graft implanted for 3 days. Silver grains 
reflecting the bound probe were observed predominantly 
in the aortic wall, particularly in the hinge region of the 
valve. There is a less intense signal in the free portion of 
the leaflet. (Original magnification ×400.) 
procollagen. This signal was greatest in the aortic wall, 
with a less intense signal in the free portion of the leaflet 
and the myocardium. In the cryothermally injured grafts, 
almost no signal was detectable xcept on the tissue 
surrounding the aortic wall. These in situ hybridization 
results correspond to the histologic findings, that is, gene 
expression is found only in tissues where cells are also 
present; no gene expression is observed in the acellular 
areas. 
Discussion 
These results demonstrated that fibroblast viabil- 
ity of both fresh and cryopreserved aortic valve 
grafts remains intact after 3 days of implantation. 
This viability persists similarly in syngeneic and 
strongly allogeneic grafts. The increase in gene 
expression for procollagen exceeding that observed 
in native aortic roots suggests a capacity for repair 
and regeneration i grafts at this early duration of 
implantation. This may help to explain the excellent 
early results of aortic valve allograft implantation 
that are observed clinically. It is the impression of 
some investigators that the long-term success of 
allograft valves is related to the viability of the valve 
fibroblasts.l, 7-9 It is logical to expect he structural 
integrity of the valve to depend on the maintenance 
of the extracellular matrix, which in turn depends on 
functioning fibroblasts. The fibroblasts are respon- 
sible for continuous degradation and synthesis of 
extracellular matrix proteins and must participate at 
some level in repairing and remodeling of the valve 
tissue. Previously published studies have not inves- 
tigated the gene expression for these important 
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Fig. 4. Dark-field photomicrograph showing localization 
of al(I) proeollagen mRNA by in situ hybridization in a 
cryopreserved allogeneic graft implanted for 3 days. Silver 
grains reflecting the bound probe were observed in a 
distribution similar to that in the fresh syngeneic graft (see 
Fig. 2). (Original magnification ×400.) 
structural proteins. The present study, therefore, is 
significant for demonstrating in vivo fibroblast via- 
bility as evidenced by performance of a metabolic 
activity that may be important in assuring continued 
valve function. 
The aortic valve leaflet consists of a cellular 
component and a noncellular component. Part of 
the cellular component is the endothelium, forming 
a smooth boundary lining the leaflet. Smooth muscle 
is also present in the aortic wall, and a contribution 
from these cells must also be considered. Fibroblasts 
exist within the noncellular matrix, which is com- 
posed primarily of collagen, elastin, and proteogly- 
cans. Collagen represents he largest portion of the 
extracellular matrix in the aortic valve, and type I 
collagen is the most abundant type. 15 Maintenance 
of the normal rate of type I collagen synthesis may 
be important for preservation ofnormal tissue struc- 
ture and :function. If the cellular viability of fibro- 
blasts helps to determine the capacity of the graft to 
resist deterioration, this may be mediated by the 
production of procollagen. 
For a negative control, this study used a group of 
grafts in which the cells had been cryothermally 
injured by rapid freezing and thawing. These grafts, 
which were essentially acellular, had diminished 
procollagen gene expression compared with all 
other groups. This negative control group was im- 
portant for two reasons: (1) it demonstrates that 
detection of increases in procollagen gene expres- 
sion requires fibroblast viability and (2) it suggests 
that the donor cells, not the recipient tissues, are the 
Fig. 5. Dark-field photomicrograph showing localization 
of cq(I) procollagen mRNA by in situ hybridization in a 
cryothermally injured graft implanted for 3 ays. Silver 
grains reflecting the bound probe were observed only on 
the adventitia of the aortic wall, indicating an absence of 
gene expression throughout most of the graft. (Original 
magnification ×400.) 
Table I. Transcriptional ctivity of type I 
procollagen mRNA in grafts and native aortic valves 
Transcriptional 
Sample Graft/ activity Fold 
Group (n) native (mean +_ SEM) increase 
Fresh syngeneic 13 Graft 2.38 _+ 0.75 
Native 0.74 _+ 0.22 
Fresh allogeneic 11 Graft 1.30 +_ 0.25 
Native 0.46 _+ 0.10 
Cryopreserved 10 Graft 2.53 + 0.61 
syngeneic 
Native 0.80 -+ 0.17 
Cryopreserved 14 Graft 1.08 _+ 0.54 
allogeneic 
Native 0.59 _+ 0.37 
Cryothermally 8 Graft 0.52 _+ 0.09 
injured 
controls 
Native 0.82 _+ 0.14 
3.64 _+ 0.53* 
3.58 _+ 0.68* 
3.31 -+ 0.49? 
3.10 _+ 0.35t 
0.64 _+ 0.03 
*p < 0.01 versus cryothermally injured controls. 
tp < 0.05 versus cryothermally injured controls. 
source of the gene expression. It is possible that with 
longer times of observation, recipient cells may 
repopulate the graft and serve as a source for 
protein synthesis. It is unlikely, however, that such 
recipient cell migration could occur in the short time 
frame used in this study. 
Although one of the underlying premises of this 
investigation is that procollagen gene expression, 
procollagen protein synthesis, and collagen assem- 
bly are advantageous in maintaining raft structure 
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and function, this is by no means agiven. Additional 
investigations will be necessary to support this 
premise. It may eventually prove to be the case that 
procollagen overproduction leads to fibrosis, calcifi- 
cation, and graft stenosis. Because the pathologic 
fate of allograft valves is not consistent, he patho- 
physiologic events leading to the common endpoint 
of "allograft failure" may be markedly divergent. 
Whereas ome allograft valve failures are character- 
ized by attenuation of leaflets and insufficiency, 
others are noteworthy for fibrosis, loss of compli- 
ance, and mineralization. 16'17 It is not known 
whether these seemingly opposite types of events 
can be related to a uniform cellular process. 
Similarly, the lack of apparent difference in histo- 
compatible and incompatible grafts may be an arti- 
fact of a short-term study. Immunologic influences 
are unlikely to become manifest within a 3-day 
period but may be considerably stronger over a 
longer time. Allograft valves are almost always used 
without HLA matching between donors and recipi- 
ents, and even matching by ABO blood group 
antigens is done in a minority of cases. Although 
sensitization of valve graft recipients has been 
shown in both human beings 18' 19 and experimental 
animals,ll, 2o-22 the performance of allograft valves 
seems unaffected by the degree of immunologic 
difference between donor and recipient)' 6,23 Ex- 
perimental findings support a limited link between 
histocompatibility and allograft valve calcification. 21
The importance and role of the increase of pro- 
collagen gene expression i aortic valve grafts needs 
further study now that the methods of investigating 
the modulators of gene expression are available. 
Procollagen gene expression is regulated both posi- 
tively and negatively by a variety of factors such as 
growth factors, cytokines, and other modulators of 
gene expression. 24 In vivo studies of regulation, 
composition, interactions, and organization of vari- 
ous connective tissues are complex and difficult. For 
this reason, cell culture systems are frequently used 
for these purpose. Cells in culture, however, are not 
exposed to many of the modulating influences that 
exist in vivo. Most experiments examining the effects 
of exogenous agents on collagen gene expression 
have examined individual factors, whereas, in vivo, a 
given cell will always be exposed to several factors 
simultaneously. It seems likely that many of these 
factors acting in combination will have different 
effects from those acting separately. Most previously 
published studies examining the cellular viability of 
allograft valves use specimens obtained immediately 
after harvest, disinfection, or thawing, but not after 
subsequent implantation. 7-9' 25, 26 Thus influences of 
implantation, including immunologic consequences, 
are not considered. Such studies may not be able to 
predict long-term fibroblast viability in implanted 
valves. Therefore determining fibroblast viability in 
allograft valves after implantation is valuable. Pre- 
vious studies from this laboratory demonstrated that 
early endothelial viability was well maintained in 
fresh grafts, whether syngeneic or allogeneic, but 
completely abolished in cryopreserved grafts] ° The 
present study thereby illustrates a sharp divergence 
of the pathologic fate of these two cellular compo- 
nents of the valve and emphasizes the importance of
analyzing the cell populations independently. 
In conclusion, this experiment successfully dem- 
onstrates the use of molecular techniques to evalu- 
ate procollagen gene expression in aortic valve 
grafts at an early period after transplantation. These 
observations suggest hat during this period, graft 
repair processes are present and perhaps acceler- 
ated compared with those of native tissues. This also 
suggests that fibroblast viability is maintained and 
that cryopreservation a d histocompatibility differ- 
ences do not alter the ability of these cells to 
respond appropriately to endogenous signals. 
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